Literature DB >> 1355405

Oral cancer progression and c-erbB-2/neu proto-oncogene expression.

L Hou1, D Shi, S M Tu, H Z Zhang, M C Hung, D Ling.   

Abstract

Monoclonal antibody PAb3 to c-erbB-2/neu protein was utilized in the immunoperoxidase staining of 86 human specimens from oral mucosa. These tissue specimens represented a spectrum from 7 normal to 9 simple hyperplasia, 15 mild dysplasia, 14 moderate dysplasia, 20 severe dysplasia and 21 squamous cell carcinoma. Our study indicated that as the cells acquire a more malignant phenotype, there was a progressive increase in neu expression. It also suggested that neu may be involved in the development of oral cancers and that its evaluation in the early stages may assist in the diagnosis and management of oral cancers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355405     DOI: 10.1016/0304-3835(92)90234-m

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Her-2 immunohistochemical expression in oral squamous cell carcinomas is associated with polysomy of chromosome 17, not Her-2 amplification.

Authors:  Dimitrios Papavasileiou; Konstantinos Tosios; Panos Christopoulos; Nikolaos Goutas; Dimitrios Vlachodimitropoulos
Journal:  Head Neck Pathol       Date:  2009-08-22

Review 2.  HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer.

Authors:  Kazi M Ahmed; Ning Cao; Jian Jian Li
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

3.  Combining epitope-distinct antibodies to HER2: cooperative inhibitory effects on invasive growth.

Authors:  A Emde; C-R Pradeep; D A Ferraro; N Ben-Chetrit; M Sela; B Ribba; Z Kam; Y Yarden
Journal:  Oncogene       Date:  2010-12-06       Impact factor: 9.867

4.  Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.

Authors:  P O-charoenrat; P Rhys-Evans; W J Court; G M Box; S A Eccles
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

5.  Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease.

Authors:  R Kremser; P Obrist; G Spizzo; H Erler; D Kendler; G Kemmler; G Mikuz; C Ensinger
Journal:  Virchows Arch       Date:  2003-03-08       Impact factor: 4.064

6.  Arecoline induced disruption of expression and localization of the tight junctional protein ZO-1 is dependent on the HER 2 expression in human endometrial Ishikawa cells.

Authors:  Sarbani Giri; Kevin M Poindexter; Shyam N Sundar; Gary L Firestone
Journal:  BMC Cell Biol       Date:  2010-07-06       Impact factor: 4.241

Review 7.  Biological staging of head and neck cancer and its role in developing effective treatment strategies.

Authors:  W M Lydiatt; S P Schantz
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

Review 8.  Invasion and metastasis.

Authors:  D Boyd
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

9.  Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats.

Authors:  Eleftherios Vairaktaris; Lambros Goutzanis; Stavros Vassiliou; Sofia Spyridonidou; Emeka Nkenke; Georgios Papageorgiou; Pashalis Strantzias; Andreas Lazaris; Christos Yapijakis; Efstratios Patsouris
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-18       Impact factor: 4.553

Review 10.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.